rs773225085
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PM4_SupportingBS1_Supporting
The NM_025137.4(SPG11):c.6223_6224insGAA(p.Phe2074_Asn2075insArg) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,613,956 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. N2075N) has been classified as Likely benign.
Frequency
Consequence
NM_025137.4 inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPG11 | NM_025137.4 | c.6223_6224insGAA | p.Phe2074_Asn2075insArg | inframe_insertion | 33/40 | ENST00000261866.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPG11 | ENST00000261866.12 | c.6223_6224insGAA | p.Phe2074_Asn2075insArg | inframe_insertion | 33/40 | 1 | NM_025137.4 |
Frequencies
GnomAD3 genomes ? AF: 0.0000658 AC: 10AN: 152012Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000755 AC: 19AN: 251490Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135920
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461826Hom.: 0 Cov.: 32 AF XY: 0.0000316 AC XY: 23AN XY: 727210
GnomAD4 genome ? AF: 0.0000657 AC: 10AN: 152130Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 10AN XY: 74362
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 11 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Aug 23, 2022 | This variant, c.6223_6224insGAA, results in the insertion of 1 amino acid(s) of the SPG11 protein (p.Phe2074_Asn2075insArg), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs773225085, gnomAD 0.1%). This variant has been observed in individual(s) with clinical features of amyotrophic lateral sclerosis (PMID: 32166880). ClinVar contains an entry for this variant (Variation ID: 572161). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The inframe insertion variant c.6223_6224insGAA (p.Phe2074_Asn2075insArg) in SPG11 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Phe2074_Asn2075insArg variant has allele frequency 0.008% in gnomAD exomes and novel in 1000 Genomes. This variant has been reported to the ClinVar database as Uncertain Significance. The insertion of amino acid Arg between amino acids Phe at position 2074 and Asn at position 2075 changing protein sequence and it might alter its composition and physico-chemical properties. The observed variant is not in repeat region. For these reasons, this variant has been classified as Uncertain Significance (VUS). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | - | - - |
Charcot-Marie-Tooth disease axonal type 2X Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 20, 2020 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | - | - - |
Amyotrophic lateral sclerosis type 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at